HealthMedical Research
mRNA Cancer Vaccine Slashes Melanoma Recurrence by 49%
Moderna and Merck's mRNA vaccine reduced melanoma recurrence risk by 49% over five years, offering new hope for advanced skin cancer patients.
—4 min read
Category
Medical Research
3 articles
HealthMedical Research
mRNA Vaccine Shows Lasting Protection Against Melanoma
A personalized mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 49% over five years, according to new clinical trial data.
—4 min read
HealthMedical Research
Experimental Pill Doubles Survival in Pancreatic Cancer
New oral drug daraxonrasib nearly doubled survival in metastatic pancreatic cancer patients, marking a breakthrough against one of the deadliest cancers.
—5 min read